Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials.
[This corrects the article DOI: 10.1371/journal.pone.0307800.].
Saved in:
Main Authors: | Fitriyadi Kusuma, Glenardi Glenardi, Ghea Mangkuliguna, Hariyono Winarto, Gatot Purwoto, Tofan Widya Utami, Tricia Dewi Anggraeni |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials
Published: (2024-01-01) -
The implementation and side effect management of immune checkpoint inhibitors in gynecologic oncology: a JAGO/NOGGO survey
by: Maximilian Riedel, et al.
Published: (2025-01-01) -
Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
by: Ziting Peng, et al.
Published: (2025-02-01) -
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01) -
Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function
by: Maor Tzuberi, et al.
Published: (2025-01-01)